Olfarma ApS: Financial statements 2020
CVR: 40241167
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Olfarma ApS (CVR 40241167) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 86,515 and a net result of DKK 28,950 compared with DKK 7,255 the year before. That is an increase of 107.6% compared with the year before. The profit margin was 33.5%. Equity in the 2020 report amounted to DKK 46,205. The solvency ratio was 9.1%.
- Revenue
- DKK 86,515
- Gross Profit
- DKK 38,515
- Profit/Loss
- DKK 28,950
- Equity
- DKK 46,205
- Total Assets
- DKK 505,350
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 87 t. | 39 t. | 29 t. | 46 t. | - |
| 2019 | 42 t. | 11 t. | 7 t. | 17 t. | - |
How creditworthy is Olfarma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Olfarma ApS has published its interim report for the period February 7, 2019 – December 31, 2019.
About Olfarma ApS
Olfarma ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jørgen Claus Oldenburg. The company is owned by Jørgen Claus Oldenburg and Anne Merete Oldenburg. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 686,093 and a net result of DKK 14,104 compared with DKK 59,935 the year before. Equity in the 2025 report amounted to DKK 285,196.